
Valuation analysis

- P/E
- Price
- High
- Median
- Low
- P/B
- Price
- High
- Median
- Low
- P/S
- Price
- High
- Median
- Low
- Dividend Yield
- Price
- High
- Median
- Low
Institutional View & Shareholder
Analyst Ratings
- Price--
- Highest--
- Lowest--
Last night’s U.S. session was packed with moves and news. Here’s what caught our attention:
$NVIDIA(NVDA.US)
I’ve noticed that people keep making the same mistake. They assume AI will always stay trapped on a screen. To me, that is such a limited way of thinking.
Once intelligence is embedded ...
Tesla is positioning itself not just as an automaker but as a physical-AI company. The Optimus robot and the Robotaxi service aren’t side projects, they’re core to the vision. $Tesla(TSLA.US)
Achieving annual sales of one million humanoid robots by 2030 is our long-term goal.
$Recursion Pharmaceuticals(RXRX.US) Recursion Pharmaceuticals (RXRX.US) vs. XtalPi (2228.HK)$XTALPI(02228.HK) In-depth competitive benchmarking analysis: Comparison of technological pathways, business...




